Scientific article
Review
OA Policy
English

Management of patients with nephrotic syndrome

Published inSchweizerische medizinische Wochenschrift, vol. 139, no. 29-30, p. 416-422
Publication date2009
Abstract

Nephrotic syndrome is characterised by proteinuria >3.5 g/24h, oedema, hypoalbuminaemia and hyperlipidaemia. Several glomerular diseases, either primary or secondary, may lead to nephrotic syndrome. Investigations for nephrotic syndrome include immunological and infectious evaluations. Renal biopsy is often mandatory, except in diabetes. Depending on aetiology specific treatment, often with immunosuppressive agents, may be implemented. In any cases nonspecific treatment should be started with ACE inhibitors or ARBs. Urinary protein loss leads to several complications: water and sodium retention, hyperlipidaemia, increased risk of thromboembolism and infection, anaemia and alteration of mineral metabolism. Each of these complications must be identified.

Keywords
  • Anemia/etiology
  • Angiotensin II Type 1 Receptor Blockers/*therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
  • Dyslipidemias/etiology
  • Edema/etiology
  • Humans
  • Hypertension/drug therapy/etiology
  • Nephrotic Syndrome/complications/diagnosis/*drug therapy
  • Thromboembolism/etiology
Citation (ISO format)
DE SEIGNEUX, S., MARTIN, Pierre-Yves. Management of patients with nephrotic syndrome. In: Schweizerische medizinische Wochenschrift, 2009, vol. 139, n° 29-30, p. 416–422. doi: 10.4414/smw.2009.12477
Main files (1)
Article
accessLevelPublic
Identifiers
Journal ISSN0036-7672
932views
618downloads

Technical informations

Creation23/04/2012 10:26:45
First validation23/04/2012 10:26:45
Update time14/03/2023 17:23:00
Status update14/03/2023 17:23:00
Last indexation29/10/2024 19:23:32
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack